Nevertheless, Krejcik et al. [56] showed a significant decrease of CD38 expression in MM cells of patients enrolled in the GEN503 clinical study, where Dara was combined with lenalidomide and dexamethasone. This evidence concerns the gene CD38 and Miyoshi myopathy.